DoD Rare Cancers, Idea Development Award
Defense Health Agency Contracting Activity - DHACA · Department of Defense
At a glance
DoD Rare Cancers, Idea Development Award is a closed federal grant opportunity from the Defense Health Agency Contracting Activity - DHACA (Department of Defense). The application deadline was October 6, 2025. Total estimated funding is $6.86M across about 14 awards. The notice is unrestricted by applicant type, subject to any clarifications in the notice. Cost sharing is not required. It is funded under Assistance Listing 12.420 (Military Medical Research and Development).
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- May 1, 2025Posted
- Oct 6, 2025Application deadline
- Posted
- May 1, 2025
- Close date
- Oct 6, 2025
- Award floor
- Not specified
- Award ceiling
- Not specified
- Est. total funding
- $6,860,000
- Implied average award
- $490,000 calculated
- Expected awards
- 14
- Cost sharing
- Not required
- Funding instrument
- Grant
- Opportunity category
- Discretionary
Typical awards for this program (SAM.gov listing for ALN 12.420, not this notice): This Assistance Listing supports approximately 30 or more programs each year. Overall, awards are expected to range from $100,000 to $20M (consortium) depending on the funding priorities, anticipated number of awards, and project activity/scope within each program for an award period, on average, of 3 to 4 years. The maximum award amount, if any, is specified in each Program Announcement or Broad Agency Announcement.
Implied average = estimated total funding ÷ expected number of awards, calculated by GrantsJunction. Actual awards vary.
Who can apply
- Unrestricted (any entity type)
A quick check against the listed applicant types — other requirements in the notice still apply.
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
Summary: The fiscal year 2025 (FY25) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation.
Distinctive Features:
· Applications are encouraged to include an exploratory aim or sub-aim to support any necessary discovery-driven research.
· Preliminary data with disease-specific rationale are required. However, these data do not necessarily need to be derived from studies of the proposed rare cancer type(s)/subtype(s) under study.
· Research should have high potential impact on rare cancers and the patient community.
Funding Details: (New for FY25) Funding limits are now listed as total cost limits, which is the combination of both direct and indirect costs.
Full announcement & documents
The full announcement has the complete rules — page limits, required attachments, evaluation criteria and any letter-of-intent dates. Files download directly from Grants.gov.
Assistance Listing
What is an ALN?Reported obligations under ALN 12.420
Historical data · not a predictionAgency contact (as published)
Jamie Shortall Grant Officer
help@eBRAP.org
301-619-2393
Quick answers
Who is eligible to apply for “DoD Rare Cancers, Idea Development Award”?
The notice lists eligibility as unrestricted — open to any type of entity — subject to clarifications in the notice's additional eligibility information.
How much funding is available through “DoD Rare Cancers, Idea Development Award”?
Per the notice, total estimated program funding is $6,860,000 and the agency expects to make about 14 awards.
How do I apply for “DoD Rare Cancers, Idea Development Award”?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity HT942525RCRPIDA), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
DoW Melanoma Research Program Focused Program Award – Rare Melanomas
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 14, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Melanoma Research Program Idea Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 14, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Autism Idea Development Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 22, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Joint Warfighter Medical, Military Medical Research and Development Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Nov 16, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Rare Cancers Idea Development Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Nov 18, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Rare Cancers Resource and Community Development Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Nov 18, 2026
- Who can apply
- Unrestricted (any entity type)